2m 2m 2m 2m 2m 2m 2m
AURA BIOSCIS (AURA)
NASDAQ
$6.62+$0.16 (+2.46%)
Price as of Oct 22, 2026 6:18 PM EDT- $669.9MMarket Cap
- 12.15%1-Year Change
- BiotechnologyIndustry
AURA BIOSCIS (AURA)
$6.62+$0.16 (+2.46%)
AURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.46 | ||
Change | -$0.10 (-1.52%) | ||
Open | $6.46 | ||
High | $6.61 | ||
Low | $6.38 | ||
Previous Close | $6.56 | ||
Volume | 933,595 | ||
30-Day Average Volume | 925,357 | ||
1-Week Change | 4.70% | ||
1-Month Change | 1.57% | ||
1-Year Change | 12.15% | ||
3-Year Change | -23.10% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 103.7M | ||
Total Assets | $348.1M | ||
Market Cap | $669.9M | ||
Enterprise Value | $602.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$45.6M | ||
Free Cash Flow | -$32.5M | ||
EBIT | -$45.6M | ||
EBITDA | -$45.3M | ||
Net Working Capital | $309.5M | ||
EPS | -$0.48 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -13 | ||
PEG | -3 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue